Negative Prognostic Impact of the Coexpression of Epidermal Growth Factor Receptor and c-erbB-2 in Locally Advanced Cervical Cancer

Publisher： Karger

E-ISSN： 1423-0232|76|2|133-141

ISSN： 0030-2414

Source： Oncology, Vol.76, Iss.2, 2009-01, pp. : 133-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amplification of the c-met, c-erbB-2 and Epidermal Growth Factor Receptor Gene in Human Gastric Cancers: Correlation to Clinical Features

By  

Oncology, Vol. 55, Iss. 5, 1998-08 ,pp. : 475-481

Karger

Access to resources Recommend Favorite

The Prognostic Significance of c-erbB-2 Serum Protein in Metastatic Breast Cancer

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 33-38

Karger

Access to resources Recommend Favorite

ErbB2 Growth Factor Receptor, a Marker for Neuroendocrine Cells?

By  

Pancreatology, Vol. 5, Iss. 1, 2005-04 ,pp. : 44-58

Karger

Access to resources Recommend Favorite

Prognostic Role of Apoptotic, Bcl-2, c-erbB-2 and p53 Tumor Markers in Salivary Gland Malignancies

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 389-398

Karger

Access to resources Recommend Favorite

Impact of clinicopathological characteristics on the efficacy of neoadjuvant therapy in patients with human epidermal growth factor receptor‐2‐positive breast cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 4, 2018-02 ,pp. : 844-853

John Wiley & Sons Inc

Access to resources Recommend Favorite